VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update

World News: . []

CAMBRIDGE Mass Nov 09 2018 GLOBE NEWSWIRE -- VBI Vaccines Inc NASDAQ VBIV VBI a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines today reported financial result...

More news and information about VBI Vaccines, Inc.

Published By:

Globe Newswire: 12:00 GMT Friday 9th November 2018

Published: .

Search for other references to "vaccines" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us